GH - Guardant Health - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

GH is currently covered by 17 analysts with an average price target of $59.69. This is a potential upside of $21.69 (57.08%) from yesterday's end of day stock price of $38.

Guardant Health's activity chart (see below) currently has 122 price targets and 128 ratings on display. The stock rating distribution of GH is 96.15% BUY and 3.85% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 48.66% with an average time for these price targets to be met of 165.65 days.

Highest price target for GH is $65, Lowest price target is $40, average price target is $51.92.

Most recent stock forecast was given by DAVID WESTENBERG from PIPER SANDLER on 06-May-2025. First documented stock forecast 29-Oct-2018.

Currently out of the existing stock ratings of GH, 50 are a BUY (96.15%), 2 are a HOLD (3.85%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$60

$22 (57.89%)

$50

18 days ago
(06-May-2025)

7/11 (63.64%)

$18.07 (43.10%)

220

Buy

$57

$19 (50.00%)

$52

19 days ago
(05-May-2025)

3/5 (60%)

$12.95 (29.40%)

439

Buy

$65

$27 (71.05%)

$60

23 days ago
(01-May-2025)

4/10 (40%)

$16.13 (33.01%)

183

Buy

$55

$17 (44.74%)

$44

1 months 28 days ago
(26-Mar-2025)

1/4 (25%)

$9.16 (19.98%)

242

Buy

$59

$21 (55.26%)

$39

3 months ago
(24-Feb-2025)

2/3 (66.67%)

$11.6 (24.47%)

24

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is GH (Guardant Health) average time for price targets to be met?

On average it took 165.65 days on average for the stock forecasts to be realized with a an average price target met ratio 48.66

Which analyst has the current highest performing score on GH (Guardant Health) with a proven track record?

PUNEET SOUDA

Which analyst has the most public recommendations on GH (Guardant Health)?

Puneet Souda works at LEERINK and has 19 price targets and 10 ratings on GH

Which analyst is the currently most bullish on GH (Guardant Health)?

Patrick Donnelly with highest potential upside - $48.48

Which analyst is the currently most reserved on GH (Guardant Health)?

Max Masucci with lowest potential downside - -$1

Guardant Health in the News

Guardant Health to Participate in Upcoming Investor Conferences

PALO ALTO, Calif., May 08, 2025–(BUSINESS WIRE)–Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the company will be participating in the following investor conferences. BofA Securities 2025 Healthcare Conference in Las Vegas, NV Fireside chat on Wednesday, May 14th at 3:40 p.m. Pacific Time Jefferies Global Healthcare Conference in New York,...

TIME Names Guardant Health Co-CEOs to 2025 TIME100 Health List of the 100 Most Influential People in Global Health This Year

PALO ALTO, Calif., May 08, 2025–(BUSINESS WIRE)–Today TIME named to its 2025 TIME100 Health list co-CEOs Helmy Eltoukhy and AmirAli Talasaz of Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company. The list recognizes and honors the top 100 most influential people in global health this year. “The inclusion on TIME100 Health’s list is...
Show more

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?